REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC
. Form 8.3 - WILLIS TOWERS WATSON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 18 August 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) |
Relevant securities | ||||
1,512,098 |
1.17% |
472,431 |
0.37% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
355,000 |
0.28% |
383,659 |
0.30% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
| purchase/sell: | 0 |
0.00% |
0 |
0.00% |
|
|
|
|
|
||
| TOTAL: |
|
|
|
|
|
1,867,098 |
1.45% |
856,090 |
0.66% |
||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase |
2 |
200.0100 USD |
Purchase |
2 |
202.1300 USD |
Purchase |
5 |
201.8700 USD |
Purchase |
20 |
201.0000 USD |
Purchase |
26 |
202.0000 USD |
Purchase |
71 |
200.9367 USD |
Purchase |
100 |
201.0200 USD |
Purchase |
100 |
201.9400 USD |
Purchase |
140 |
201.5621 USD |
Purchase |
172 |
201.3855 USD |
Purchase |
200 |
201.2750 USD |
Purchase |
300 |
202.5400 USD |
Purchase |
300 |
201.9866 USD |
Purchase |
567 |
201.9231 USD |
Purchase |
576 |
200.8854 USD |
Purchase |
700 |
201.4508 USD |
Purchase |
2,915 |
201.4355 USD |
Purchase |
3,055 |
201.4413 USD |
Purchase |
4,854 |
201.3100 USD |
Purchase |
6,949 |
200.9376 USD |
Purchase |
18,730 |
201.8247 USD |
Purchase |
128,269 |
201.2012 USD |
Purchase |
128,269 |
201.2013 USD |
Sale |
2 |
200.0100 USD |
Sale |
7 |
201.9442 USD |
Sale |
11 |
201.9800 USD |
Sale |
38 |
201.4400 USD |
Sale |
70 |
201.3800 USD |
Sale |
71 |
200.9367 USD |
Sale |
76 |
202.9000 USD |
Sale |
78 |
202.1900 USD |
Sale |
100 |
201.5600 USD |
Sale |
100 |
200.9800 USD |
Sale |
100 |
202.0800 USD |
Sale |
101 |
202.0906 USD |
Sale |
200 |
201.9600 USD |
Sale |
200 |
201.6950 USD |
Sale |
200 |
201.8000 USD |
Sale |
200 |
201.2750 USD |
Sale |
300 |
201.7500 USD |
Sale |
304 |
201.6313 USD |
Sale |
318 |
201.2988 USD |
Sale |
400 |
201.5837 USD |
Sale |
410 |
201.7295 USD |
Sale |
600 |
201.7483 USD |
Sale |
601 |
201.7283 USD |
Sale |
946 |
201.0173 USD |
Sale |
1,127 |
201.7060 USD |
Sale |
1,143 |
202.2355 USD |
Sale |
1,199 |
201.7008 USD |
Sale |
1,440 |
201.5261 USD |
Sale |
1,501 |
200.5450 USD |
Sale |
1,615 |
201.3656 USD |
Sale |
1,625 |
201.4971 USD |
Sale |
1,930 |
201.6832 USD |
Sale |
2,568 |
201.1154 USD |
Sale |
2,819 |
201.0692 USD |
Sale |
2,855 |
201.4235 USD |
Sale |
3,603 |
200.9510 USD |
Sale |
3,620 |
200.9622 USD |
Sale |
3,910 |
200.9970 USD |
Sale |
4,147 |
201.3100 USD |
Sale |
4,472 |
200.9455 USD |
Sale |
4,772 |
201.1720 USD |
Sale |
7,219 |
201.0636 USD |
Sale |
7,583 |
201.2145 USD |
Sale |
8,864 |
201.1637 USD |
Sale |
10,379 |
201.1308 USD |
Sale |
16,869 |
201.7932 USD |
Sale |
66,705 |
201.2434 USD |
Sale |
128,269 |
201.2012 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing |
| and any other person relating to the voting rights of any relevant securities under any option |
| referred to on this form or relating to the voting rights or future acquisition or disposal of any |
| relevant securities to which any derivative referred to on this form is referenced. If none, this |
| should be stated. |
| NONE |
Is a Supplemental Form 8 attached? (Note 9) YES/NO
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 19 Aug 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200819005299/en/
BARCLAYS PLC
Recent news on Barclays
See all newsREG - Inter-American Dev - Issue of Debt
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
AnnouncementREG - Barclays PLC Kitwave Group PLC - Form 8.3 KITWAVE GROUP PLC
Announcement